The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of zeaxanthin alone or in combination with pembrolizumab in metastatic solid tumors.
 
Philip Friedlander
Stock and Other Ownership Interests - GE Healthcare; Gilead Sciences; Iovance Biotherapeutics; Iovance Biotherapeutics (I)
Consulting or Advisory Role - Castle Biosciences; Sun BioPharma
Research Funding - Jazz Pharmaceuticals; Merck; Regeneron
Travel, Accommodations, Expenses - Sun BioPharma
 
Eleonora Teplinsky
Honoraria - Sermo
Consulting or Advisory Role - Abbvie; Daiichi Sankyo/Astra Zeneca; Immunogen; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; OncLive/MJH Life Sciences
 
Kevin Wood
No Relationships to Disclose
 
Eli Kirshner
No Relationships to Disclose
 
Jae Cho
Employment - Valley Medical Group